Martin L Bocks
Journal: Interventional cardiology clinics 2026;15(2):263-278
PMID: 41850801
This article reviews the evolution and current development of stent platforms for pediatric and congenital heart disease. It highlights limitations of off-label use of adult stents, the emergence of growth-compatible technologies such as the Renata Minima, and the promise and challenges of bioresorbable scaffolds. Emphasis is placed on engineering strategies-including , computational modeling, material biocompatibility, and patient-specific design-that are accelerating innovation in this field. The review synthesizes recent progress across multiple platforms and provides clinical insights into optimizing stent selection and future integration into pediatric interventional strategies.
Copyright © 2025 Elsevier Inc. All rights reserved.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.